277 related articles for article (PubMed ID: 14638774)
1. Characterization of a protective monoclonal antibody recognizing Staphylococcus aureus MSCRAMM protein clumping factor A.
Hall AE; Domanski PJ; Patel PR; Vernachio JH; Syribeys PJ; Gorovits EL; Johnson MA; Ross JM; Hutchins JT; Patti JM
Infect Immun; 2003 Dec; 71(12):6864-70. PubMed ID: 14638774
[TBL] [Abstract][Full Text] [Related]
2. Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.
Tkaczyk C; Hamilton MM; Sadowska A; Shi Y; Chang CS; Chowdhury P; Buonapane R; Xiao X; Warrener P; Mediavilla J; Kreiswirth B; Suzich J; Stover CK; Sellman BR
mBio; 2016 Jun; 7(3):. PubMed ID: 27353753
[TBL] [Abstract][Full Text] [Related]
3. Multimechanistic Monoclonal Antibodies (MAbs) Targeting Staphylococcus aureus Alpha-Toxin and Clumping Factor A: Activity and Efficacy Comparisons of a MAb Combination and an Engineered Bispecific Antibody Approach.
Tkaczyk C; Kasturirangan S; Minola A; Jones-Nelson O; Gunter V; Shi YY; Rosenthal K; Aleti V; Semenova E; Warrener P; Tabor D; Stover CK; Corti D; Rainey G; Sellman BR
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584141
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of the preclinical correlate of protection for Staphylococcus aureus clumping factor A in a murine model of infection.
Scully IL; Timofeyeva Y; Keeney D; Matsuka YV; Severina E; McNeil LK; Nanra J; Hu G; Liberator PA; Jansen KU; Anderson AS
Vaccine; 2015 Oct; 33(41):5452-5457. PubMed ID: 26319743
[TBL] [Abstract][Full Text] [Related]
5. A humanized monoclonal antibody targeting Staphylococcus aureus.
Patti JM
Vaccine; 2004 Dec; 22 Suppl 1():S39-43. PubMed ID: 15576200
[TBL] [Abstract][Full Text] [Related]
6. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant.
Josefsson E; Hartford O; O'Brien L; Patti JM; Foster T
J Infect Dis; 2001 Dec; 184(12):1572-80. PubMed ID: 11740733
[TBL] [Abstract][Full Text] [Related]
7. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of antigenic epitope of Staphylococcus aureus ClfA adhesin.
Li Y; Liu YH; Li ZJ; Li YG; Liu MY; Liu LB; Wang XG; Wang XL; Suo J; Han WY
Res Vet Sci; 2013 Jun; 94(3):490-5. PubMed ID: 23178048
[TBL] [Abstract][Full Text] [Related]
9. [Characterization of antiserum after co-immunized with adhesins expressing ClfA, FnBPA-A and FnBPA-BCD of Staphylococus aureus].
Jiang H; Su Y; Shen Y
Wei Sheng Wu Xue Bao; 2015 Oct; 55(10):1343-9. PubMed ID: 26939463
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of a conjugate vaccine composed of Staphylococcus aureus poly-N-acetyl-glucosamine and clumping factor A.
Maira-Litrán T; Bentancor LV; Bozkurt-Guzel C; O'Malley JM; Cywes-Bentley C; Pier GB
PLoS One; 2012; 7(9):e43813. PubMed ID: 22970144
[TBL] [Abstract][Full Text] [Related]
11. A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposure.
Hawkins J; Kodali S; Matsuka YV; McNeil LK; Mininni T; Scully IL; Vernachio JH; Severina E; Girgenti D; Jansen KU; Anderson AS; Donald RG
Clin Vaccine Immunol; 2012 Oct; 19(10):1641-50. PubMed ID: 22896688
[TBL] [Abstract][Full Text] [Related]
12. Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.
Veloso TR; Mancini S; Giddey M; Vouillamoz J; Que YA; Moreillon P; Entenza JM
Vaccine; 2015 Jul; 33(30):3512-7. PubMed ID: 26048778
[TBL] [Abstract][Full Text] [Related]
13. Protective immunization against Staphylococcus aureus infection in a novel experimental wound model in mice.
Schennings T; Farnebo F; Szekely L; Flock JI
APMIS; 2012 Oct; 120(10):786-93. PubMed ID: 22958286
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a humanized monoclonal antibody recognizing clumping factor A expressed by Staphylococcus aureus.
Domanski PJ; Patel PR; Bayer AS; Zhang L; Hall AE; Syribeys PJ; Gorovits EL; Bryant D; Vernachio JH; Hutchins JT; Patti JM
Infect Immun; 2005 Aug; 73(8):5229-32. PubMed ID: 16041045
[TBL] [Abstract][Full Text] [Related]
15. Role of interleukin-17A in cell-mediated protection against Staphylococcus aureus infection in mice immunized with the fibrinogen-binding domain of clumping factor A.
Narita K; Hu DL; Mori F; Wakabayashi K; Iwakura Y; Nakane A
Infect Immun; 2010 Oct; 78(10):4234-42. PubMed ID: 20679443
[TBL] [Abstract][Full Text] [Related]
16. Vaccination with clumping factor A and fibronectin binding protein A to prevent Staphylococcus aureus infection of an aortic patch in mice.
Arrecubieta C; Matsunaga I; Asai T; Naka Y; Deng MC; Lowy FD
J Infect Dis; 2008 Aug; 198(4):571-5. PubMed ID: 18613794
[TBL] [Abstract][Full Text] [Related]
17. Immune response and functional role of antibodies raised in heifers against a Staphylococcus aureus CP5 lysate and recombinant antigens vaccine formulated with Iscom Matrix adjuvant.
Camussone CM; Pujato N; Renna MS; Veaute CM; Morein B; Marcipar IS; Calvinho LF
Vet Immunol Immunopathol; 2014 Dec; 162(3-4):96-107. PubMed ID: 25454469
[TBL] [Abstract][Full Text] [Related]
18. Relationship between virulence factor genes in bovine Staphylococcus aureus subclinical mastitis isolates and binding to anti-adhesin antibodies.
Scarpa M; Piccinini R; Brun P; Grillo A; Palù G; Mengoli C; Daprà V; Castagliuolo I; Zecconi A
J Dairy Res; 2010 May; 77(2):159-67. PubMed ID: 20030902
[TBL] [Abstract][Full Text] [Related]
19. Lessons from the Crystal Structure of the S. aureus Surface Protein Clumping Factor A in Complex With Tefibazumab, an Inhibiting Monoclonal Antibody.
Ganesh VK; Liang X; Geoghegan JA; Cohen ALV; Venugopalan N; Foster TJ; Hook M
EBioMedicine; 2016 Nov; 13():328-338. PubMed ID: 27789272
[TBL] [Abstract][Full Text] [Related]
20. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
